Cohort of IPF Patients Experiencing an Exacerbation
ConditionIdiopathic Pulmonary Fibrosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Gentofte, Copenhagen
About this trial
Extension of the PFBIO cohort which includes patients with newly diagnosed idiopathic pulmonary fibrosis (IPF) for longitudinal follow-up for up to 5 years.
In the PFBIO-EXA extension, patients are included if they experience an exacerbation, or other increase in respiratory symptoms requiring hospital admission, for further collection of clinical and biological data.
Eligibility criteria
Qualifiers
Admitted with an increase in respiratory symptoms
Already included in PFBIO or included simultaneously in PFBIO and PFBIO-EXA
Age at least 18 years
Disqualifiers
Unable to provide informed consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
50 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov